Ken Griffin
DRIO icon

Ken Griffin’s DarioHealth DRIO Stock Holding History

Ken Griffin’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$79 – 14678
2024
Q4 		$79 Sell
5
-275
-98% -$4.76K ﹤0.01% 14387
2024
Q3 		$6.27K Buy
280
+115
+70% +$2.33K ﹤0.01% 13430
2024
Q2 		$3.93K Buy
165
+95
+136% +$2.69K ﹤0.01% 13529
2024
Q1 		$2.14K Sell
70
-35
-33% -$1.33K ﹤0.01% 14038
2023
Q4 		$3.61K Sell
105
-90
-46% -$3.21K ﹤0.01% 13575
2023
Q3 		$12.8K Sell
195
-230
-54% -$15.5K ﹤0.01% 12950
2023
Q2 		$34.1K Sell
425
-915
-68% -$69.5K ﹤0.01% 12228
2023
Q1 		$110K Sell
1,340
-245
-15% -$24.1K ﹤0.01% 11110
2022
Q4 		$136K Buy
1,585
+170
+12% +$15.3K ﹤0.01% 10761
2022
Q3 		$131K Buy
1,415
+755
+114% +$81K ﹤0.01% 10845
2022
Q2 		$81K Sell
660
-175
-21% -$20.5K ﹤0.01% 11584
2022
Q1 		$98K Sell
835
-1,470
-64% -$243K ﹤0.01% 12301
2021
Q4 		$598K Sell
2,305
-125
-5% -$38K ﹤0.01% 9230
2021
Q3 		$663K Buy
2,430
+175
+8% +$50.5K ﹤0.01% 9195
2021
Q2 		$963K Buy
2,255
+1,630
+261% +$621K ﹤0.01% 8463
2021
Q1 		$241K Buy
+625
New +$282K ﹤0.01% 11321

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Ken Griffin's DRIO Position: Q1 2026 in Review

Ken Griffin opened a new position in DarioHealth (DRIO) in Q1 2026: 20,460 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #11607 among its holdings. This is a return to the name: Ken Griffin previously reported a position in DRIO as recently as Q4 2024.

Ken Griffin first reported a position in DRIO in Q2 2018 and has held it in 21 quarters since. The position peaked at $895K in Q2 2022. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

  • Ken Griffin held 20,460 shares of DarioHealth worth $164K as of Q1 2026.
  • DarioHealth was a new Ken Griffin position in Q1 2026.
  • DarioHealth made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #11607 holding.
  • Ken Griffin first reported a position in DarioHealth in Q2 2018 and has held it in 21 quarters since.
  • Ken Griffin's DarioHealth position peaked at $895K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.